Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-88
SponsorUniversity of Maryland, Baltimore
About this trial
We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.
Eligibility criteria
Qualifiers
Adults ages 18-88
Cancer diagnosis (histology verified)
Had surgical intervention, completed chemotherapy or radiation for therapeutic purposes
Documented symptoms of cancer or cancer therapy including at least one of the following: pain, anxiety, sleep difficulty, fatigue, neuropathy
Disqualifiers
Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years
Any personal (or family first degree) history of mania, schizophrenia, or other psychoses
Diagnosis and treatment of chronic pain, neuropathy, fatigue, sleep or anxiety disorder prior to cancer diagnosis
Current Hospice or palliative care only recipients
Trial design
Treatments tested in this trial
- Relievrx
- Audio Mp4
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov